Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Skeletal-related Events: XGEVA is indicated for the prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors.
Giant Cell Tumor of the Bone: XGEVA is indicated for the treatment of giant cell tumor of bone in adults or skeletally mature adolescents (see Pharmacology: Pharmacodynamics: Clinical Data under Actions).
Hypercalcemia of Malignancy: XGEVA is indicated for the treatment of hypercalcemia of malignancy that is refractory to intravenous bisphosphonate (see Pharmacology: Pharmacodynamics: Clinical Data under Actions).

Xgeva Indications/Uses

denosumab

Manufacturer:

Amgen

Distributor:

Zuellig Pharma